Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...
Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
Recommendations for digoxin use in patients with HF have changed only slightly with the 2005 guidelines. [1] The primary change was to reclassify the recommendation for use from Class I, evidence ...
Faced with these conflicting results, doubts arose regarding the potential danger of the drug, and prescriptions for digoxin for hospitalized HF patients plummeted, particularly in the United States.
Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...
We wish to report our experience with 72 patients who were treated with acetyldigitoxin. § Forty-nine were given a full digitalizing dose and maintained thereafter on acetyldigitoxin, whereas 23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results